X-13600001-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_015507.4(EGFL6):c.307C>T(p.Arg103Trp) variant causes a missense change. The variant allele was found at a frequency of 0.000346 in 1,208,487 control chromosomes in the GnomAD database, including 3 homozygotes. There are 114 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0019 ( 1 hom., 62 hem., cov: 22)
Exomes 𝑓: 0.00019 ( 2 hom. 52 hem. )
Consequence
EGFL6
NM_015507.4 missense
NM_015507.4 missense
Scores
4
8
5
Clinical Significance
Conservation
PhyloP100: 4.02
Genes affected
EGFL6 (HGNC:3235): (EGF like domain multiple 6) This gene encodes a member of the epidermal growth factor (EGF) repeat superfamily. Members of this superfamily are characterized by the presence of EGF-like repeats and are often involved in the regulation of cell cycle, proliferation, and developmental processes. The gene product contains a signal peptide, suggesting that it is secreted; an EGF repeat region consisting of 4 complete EGF-like repeats and 1 partial EGF-like repeat, 3 of which have a calcium-binding consensus sequence; an arg-gly-asp integrin association motif; and a MAM domain, which is believed to have an adhesive function. This gene is expressed early during development, and its expression has been detected in lung and meningioma tumors. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.012380391).
BP6
Variant X-13600001-C-T is Benign according to our data. Variant chrX-13600001-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 711786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAd4 at 62 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EGFL6 | NM_015507.4 | c.307C>T | p.Arg103Trp | missense_variant | 4/12 | ENST00000361306.6 | |
EGFL6 | NM_001167890.2 | c.307C>T | p.Arg103Trp | missense_variant | 4/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EGFL6 | ENST00000361306.6 | c.307C>T | p.Arg103Trp | missense_variant | 4/12 | 1 | NM_015507.4 | A2 | |
EGFL6 | ENST00000380602.3 | c.307C>T | p.Arg103Trp | missense_variant | 4/12 | 1 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00190 AC: 212AN: 111620Hom.: 1 Cov.: 22 AF XY: 0.00184 AC XY: 62AN XY: 33786
GnomAD3 genomes
AF:
AC:
212
AN:
111620
Hom.:
Cov.:
22
AF XY:
AC XY:
62
AN XY:
33786
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000547 AC: 100AN: 182840Hom.: 0 AF XY: 0.000253 AC XY: 17AN XY: 67318
GnomAD3 exomes
AF:
AC:
100
AN:
182840
Hom.:
AF XY:
AC XY:
17
AN XY:
67318
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000188 AC: 206AN: 1096814Hom.: 2 Cov.: 29 AF XY: 0.000144 AC XY: 52AN XY: 362196
GnomAD4 exome
AF:
AC:
206
AN:
1096814
Hom.:
Cov.:
29
AF XY:
AC XY:
52
AN XY:
362196
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00190 AC: 212AN: 111673Hom.: 1 Cov.: 22 AF XY: 0.00183 AC XY: 62AN XY: 33849
GnomAD4 genome
AF:
AC:
212
AN:
111673
Hom.:
Cov.:
22
AF XY:
AC XY:
62
AN XY:
33849
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
23
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
81
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 24, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
D;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
L;L
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D
REVEL
Uncertain
Sift
Pathogenic
D;D
Sift4G
Pathogenic
D;D
Polyphen
D;P
Vest4
MVP
MPC
0.89
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at